Immunotherapeutic Approaches to Cancer
With the advent of Imatinib, tremendous progress has been made in the treatment of patients with GIST.
MSKCC Opens New Immunotherapy Trial for GIST
A new clinical trial combining targeted therapy with immunotherapy has just opened at Memorial Sloan-Kettering Cancer Center (MSKCC). This trial is the culmination of extensive pre-clinical investigations by MSKCC researchers. Although treatment with Gleevec [...]